FDA clears Meridian Bioscience’s Shiga Toxin test, expanding GI testing platform

Meridian Bioscience has announced FDA 510(k) clearance of its Curian Shiga Toxin assay intended for detection and differentiation of Shiga toxin 1 and 2 within a single device, according to a company release.By adding Shiga toxin detection, the company has expanded the platform’s foodborne immunofluorescent testing capabilities beyond Campylobacter.“We are excited to continue the expansion of the Curian platform with this highly sensitive and specific assay,” Tony Serafini-Lamanna, president of Meridian Bioscience Diagnostics, said in the release. “Curian now featuresRead More